Neuroinflammation in multiple system atrophy: Response to and cause of α-synuclein aggregation

Frontiers in Cellular Neuroscience

Volumn 9, Issue NOVEMBER, 2015, Pages

  Vieira, Bruno Di Marco ^a   Radford, Rowan A ^b   Chung, Roger S ^b   Guillemin, Gilles J ^b   Pountney, Dean L ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

Astrocytes; Microglia; Multiple system atrophy; Neuroinflammation; synuclein

Indexed keywords

ALPHA SYNUCLEIN; CARBENOXOLONE;

ASTROCYTE; CELL ACTIVATION; CELL DEGENERATION; CYTOKINE RELEASE; DOWN REGULATION; HUMAN; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; PROTEIN FOLDING; REVIEW; SHY DRAGER SYNDROME; SIGNAL PROCESSING; SIGNAL TRANSDUCTION;

EID: 84947587748     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00437     Document Type: Review

References (113)

1. Ahmed, Z., Asi, Y., Sailer, A., Lees, A. J., Houlden, H., Revesz, T., et al. (2012). The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol. App. Neurobiol. 38, 4–24. doi: 10.1111/j.1365-2990.2011.01234.x
2. Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., et al. (2015). Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. doi: 10.1038/nn.4132 [Epub ahead of print].
3. Ben Haim, L., Carrillo-de Sauvage, M. A., Ceyzériat, K., and Escartin, C. (2015). Elusive roles for reactive astrocytes in neurodegenerative diseases. Front. Cell. Neurosci. 9:278. doi: 10.3389/fncel.2015.00278
4. Béraud, D., Twomey, M., Bloom, B., Mittereder, A., Ton, V., Neitzke, K., et al. (2011). a-Synuclein alters toll-like receptor expression. Front. Neurosci. 5:80. doi: 10.3389/fnins.2011.00080
5. Bhaskar, K., Konerth, M., Kokiko-Cochran, O. N., Cardona, A., Ransohoff, R. M., and Lamb, B. T. (2010). Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68, 19–31. doi: 10.1016/j.neuron.2010.08.023
6. Block, M. L., Zecca, L., and Hong, J.-S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57–69. doi: 10.1038/nrn2038
7. Brooks, D. J., Seppi, K., and Neuroimaging Working Group on, M. S. A. (2009). Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov. Disord. 24, 949–964. doi: 10.1002/mds.22413
8. Brudek, T., Winge, K., Agander, T. K., and Pakkenberg, B. (2013). Screening of Toll-like receptors expression in multiple system atrophy brains. Neurochem. Res. 38, 1252–1259. doi: 10.1007/s11064-013-1020-5
9. Burré, J., Sharma, M., and Südhof, T. C. (2014). a-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc. Natl. Acad. Sci. U. S. A. 111, E4274–E4283. doi: 10.1073/pnas.1416598111
10. Burré, J., Sharma, M., and Südhof, T. C. (2015). Definition of a molecular pathway mediating a-synuclein neurotoxicity. J. Neurosci. 35, 5221–5232. doi: 10.1523/JNEUROSCI.4650-14.2015
11. Chandran, V., and Stoessl, A. J. (2014). Imaging in multiple system atrophy. Neurol. Clin. Neurosci. 2, 178–187. doi: 10.1111/ncn3.125
12. Chen, D., Wei, X., Zou, J., Wang, R., Liu, X., Xu, X., et al. (2015). Contra-directional expression of serum homocysteine and uric acid as important biomarkers of multiple system atrophy severity: a cross-sectional study. Front. Cell. Neurosci. 9:247. doi: 10.3389/fncel.2015.00247
13. Chung, W.-S., Clarke, L. E., Wang, G. X., Stafford, B. K., Sher, A., Chakraborty, C., et al. (2013). Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504, 394–400. doi: 10.1038/nature12776
14. Colton, C. A., and Wilcock, D. M. (2010). Assessing activation states in microglia. CNS Neurol. Disord. Drug Targets 9, 174–191. doi: 10.2174/187152710791012053
15. Croisier, E., Moran, L., Dexter, D., Pearce, R., and Graeber, M. (2005). Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition. J. Neuroinflammation 2:14. doi: 10.1186/1742-2094-2-14
16. Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., and Sulzer, D. (2004). Impaired degradation of mutant a-synuclein by chaperone-mediated autophagy. Science 305, 1292–1295. doi: 10.1126/science.1101738
17. Daturpalli, S., Waudby, C. A., Meehan, S., and Jackson, S. E. (2013). Hsp90 inhibits a-synuclein aggregation by interacting with soluble oligomers. J. Mol. Biol. 425, 4614–4628. doi: 10.1016/j.jmb.2013.08.006
18. Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., et al. (2005). ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8, 752–758. doi: 10.1038/nn1472
19. Davis, C. H., Kim, K.-Y., Bushong, E. A., Mills, E. A., Boassa, D., Shih, T., et al. (2014). Transcellular degradation of axonal mitochondria. Proc. Natl. Acad. Sci. U S A 111, 9633–9638. doi: 10.1073/pnas.1404651111
20. De Keyser, J., Mostert, J. P., and Koch, M. W. (2008). Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J. Neurol. Sci. 267, 3–16. doi: 10.1016/j.jns.2007.08.044
21. Ejlerskov, P., Hultberg, J. G., Wang, J., Carlsson, R., Ambjørn, M., Kuss, M., et al. (2015). Lack of neuronal IFN-ß-IFNAR causes lewy body-and parkinson’s disease-like dementia. Cell 163, 324–339. doi: 10.1016/j.cell.2015.08.069
22. Emmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H., et al. (2010). Cell-produced a-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J. Neurosci. 30, 6838–6851. doi: 10.1523/JNEUROSCI.5699-09.2010
23. Engelender, S. (2012). a-synuclein fate: proteasome or autophagy? Autophagy 8, 418–420. doi: 10.4161/auto.19085
24. Fellner, L., and Stefanova, N. (2013). The role of glia in alpha-synucleinopathies. Mol. Neurobiol. 47, 575–586. doi: 10.1007/s12035-012-8340-3
25. Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., et al. (2013). Toll-like receptor 4 is required for a-synuclein dependent activation of microglia and astroglia. Glia 61, 349–360. doi: 10.1002/glia.22437
26. Gai, W., Pountney, D. L., Power, J., Li, Q., Culvenor, J., McLean, C., et al. (2003). a-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp. Neurol. 181, 68–78. doi: 10.1016/s0014-4886(03)00004-9
27. Gao, H.-M., Liu, B., and Hong, J.-S. (2003). Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 23, 6181–6187.
28. Gerhard, A., Banati, R., Goerres, G., Cagnin, A., Myers, R., Gunn, R., et al. (2003). [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 61, 686–689. doi: 10.1212/01.wnl.0000078192.95645.e6
29. Gilman, S., Wenning, G., Low, P. A., Brooks, D., Mathias, C., Trojanowski, J., et al. (2008). Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71, 670–676. doi: 10.1212/01.wnl.0000324625.00404.15
30. Goldman, J. S., Quinzii, C., Dunning-Broadbent, J., Waters, C., Mitsumoto, H., Brannagan, T. H., et al. (2014). Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in C9orf72. JAMA Neurol. 71, 771–774. doi: 10.1001/jamaneurol.2013.5762
31. Graeber, M. B., and Streit, W. J. (2010). Microglia: biology and pathology. Acta Neuropathol. 119, 89–105. doi: 10.1007/s00401-009-0622-0
32. Halliday, G. M., and Stevens, C. H. (2011). Glia: initiators and progressors of pathology in parkinson’s disease. Mov. Disord. 26, 6–17. doi: 10.1002/mds.23455
33. Herrera, A. J., Espinosa-Oliva, A. M., Carrillo-JiméNez, A., Oliva-Martín, M. J., García-Revilla, J., GarcíA-Quintanilla, A., et al. (2015). Relevance of chronic stress and the two faces of microglia in parkinson’s disease. Front. Cell. Neurosci. 9:312. doi: 10.3389/fncel.2015.00312
34. Hostenbach, S., Cambron, M., D’haeseleer, M., Kooijman, R., and De Keyser, J. (2013). Astrocyte loss and astrogliosis in neuroinflammatory disorders. Neurosci. Lett. 565, 39–41. doi: 10.1016/j.neulet.2013.10.012
35. Husemann, J., Loike, J. D., Anankov, R., Febbraio, M., and Silverstein, S. C. (2002). Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40, 195–205. doi: 10.1002/glia.10148
36. Ishizawa, K., Komori, T., Sasaki, S., Arai, N., Mizutani, T., and Hirose, T. (2004). Microglial activation parallels system degeneration in multiple system atrophy. J. Neuropathol. Exp. Neurol. 63, 43–52.
37. Jang, A., Lee, H. J., Suk, J. E., Jung, J. W., Kim, K. P., and Lee, S. J. (2010). Non-classical exocytosis of a-synuclein is sensitive to folding states and promoted under stress conditions. J. Neurochem. 113, 1263–1274. doi: 10.1111/j.1471-4159.2010.06695.x
38. Jensen, M., Hegelund, I., Poulsen, F., Owens, T., Zimmer, J., and Finsen, B. (1999). Microglial reactivity correlates to the density and the myelination of the anterogradely degenerating axons and terminals following perforant path denervation of the mouse fascia dentata. Neuroscience 93, 507–518. doi: 10.1016/s0306-4522(99)00139-6
39. Kettenmann, H., Hanisch, U. K., Noda, M., and Verkhratsky, A. (2011). Physiology of microglia. Physiol. Rev. 91, 461–553. doi: 10.1152/physrev.00011.2010
40. Kiffin, R., Christian, C., Knecht, E., and Cuervo, A. M. (2004). Activation of chaperone-mediated autophagy during oxidative stress. Mol. Biol. Cell 15, 4829–4840. doi: 10.1091/mbc.e04-06-0477
41. Konno, M., Hasegawa, T., Baba, T., Miura, E., Sugeno, N., Kikuchi, A., et al. (2012). Suppression of dynamin GTPase decreases alpha-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy. Mol. Neurodegener. 7:38. doi: 10.1186/1750-1326-7-38
42. Krampera, M., Cosmi, L., Angeli, R., Pasini, A., Liotta, F., Andreini, A., et al. (2006a). Role for interferon-? in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem cells 24, 386–398. doi: 10.1634/stemcells.2005-0008
43. Krampera, M., Pasini, A., Pizzolo, G., Cosmi, L., Romagnani, S., and Annunziato, F. (2006b). Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr. Opin. Pharmacol. 6, 435–441. doi: 10.1016/j.coph.2006.02.008
44. Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., et al. (1998). AlaSOPro mutation in the gene encoding a-synuclein in parkinson’s disease. Nat. Genet. 18, 106–108. doi: 10.1038/ng0298-106
45. Labandeira-Garcia, J. L., Rodriguez-Pallares, J., Villar-Cheda, B., Rodríguez-Perez, A. I., Garrido-Gil, P., and Guerra, M. J. (2011). Aging, angiotensin system and dopaminergic degeneration in the substantia nigra. Aging Dis. 2, 257–274.
46. Lantos, P. L. (1998). The definition of multiple system atrophy: a review of recent developments. J. Neuropathol. Exp. Neurol. 57, 1099–1111. doi: 10.1097/00005072-199812000-00001
47. Lee, H.-J., Kim, C., and Lee, S.-J. (2010). Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection. Oxid. Med. Cell. Longev. 3, 283–287. doi: 10.4161/oxim.3.4.12809
48. Lee, P. H., Lee, J. E., Kim, H.-S., Song, S. K., Lee, H. S., Nam, H. S., et al. (2012). A randomized trial of mesenchymal stem cells in multiple system atrophy. Ann. Neurol. 72, 32–40. doi: 10.1002/ana.23612
49. Lesage, S., Anheim, M., Letournel, F., Bousset, L., Honoré, A., Rozas, N., et al. (2013). G51D a-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann. Neurol. 73, 459–471. doi: 10.1002/ana.23894
50. Longo, D. L., Fanciulli, A., and Wenning, G. K. (2015). Multiple-system atrophy. New Engl. J. Med. 372, 249–263. doi: 10.1056/NEJMra1311488
51. Mandler, M., Valera, E., Rockenstein, E., Mante, M., Weninger, H., Patrick, C., et al. (2015). Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy. Mol. Neurodegen. 10, 1–15. doi: 10.1186/s13024-015-0008-9
52. Maphis, N., Xu, G., Kokiko-Cochran, O. N., Jiang, S., Cardona, A., Ransohoff, R. M., et al. (2015). Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain 138, 1738–1755. doi: 10.1093/brain/awv081
53. Martinez-Vicente, M., Talloczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J., Mosharov, E. V., et al. (2008). Dopamine-modified a-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest. 118:777. doi: 10.1172/JCI32806
54. McKeith, I., Dickson, D., Lowe, J., Emre, M., O’Brien, J., Feldman, H., et al. (2005). Diagnosis and management of dementia with lewy bodies third report of the DLB consortium. Neurology 65, 1863–1872. doi: 10.1212/wnl.65.12.1992-a
55. Miller, D., Johnson, J., Solano, S., Hollingsworth, Z., Standaert, D., and Young, A. (2005). Absence of a-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J. Neural Transm. 112, 1613–1624. doi: 10.1007/s00702-005-0378-1
56. Multiple-System Atrophy Research Collaboration. (2013). Mutations in COQ2 in familial and sporadic multiple-system atrophy. N. Engl. J. Med. 369:233. doi: 10.1056/NEJMoa1212115
57. Narayanan, V., and Scarlata, S. (2001). Membrane binding and self-association of a-synucleins. Biochemistry 40, 9927–9934. doi: 10.1021/bi002952n
58. Nimmerjahn, A. K., Kirchhoff, F., and Helmchen, F. (2005). Resting microglial cells are highly dinamic surveillants of brain parenchyma in vivo. Science 308, 1314–1318. doi: 10.1126/science.1110647
59. Nishie, M., Mori, F., Yoshimoto, M., Takahashi, H., and Wakabayashi, K. (2004). A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy. Neuropathol. App. Neurobiol. 30, 546–554. doi: 10.1111/j.1365-2990.2004.00564.x
60. O’Callaghan, J. P., Sriram, K., and Miller, D. B. (2008). Defining "neuroinflammation". Ann. N. Y. Acad. Sci. 1139, 318–1130. doi: 10.1196/annals.1432.032
61. Ozawa, T., Paviour, D., Quinn, N. P., Josephs, K. A., Sangha, H., Kilford, L., et al. (2004). The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127, 2657–2671. doi: 10.1093/brain/awh303
62. Park, H.-J., Bang, G., Lee, B. R., Kim, H. O., and Lee, P. H. (2011). Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism. Cell Transplant. 20, 827–835. doi: 10.3727/096368910x540630
63. Parkhurst, C. N., and Gan, W.-B. (2010). Microglia dynamics and function in the CNS. Curr. Opin. Neurobiol. 20, 595–600. doi: 10.1016/j.conb.2010.07.002
64. Pasanen, P., Myllykangas, L., Siitonen, M., Raunio, A., Kaakkola, S., Lyytinen, J., et al. (2014). A novel a-synuclein mutation A53E associated with atypical multiple system atrophy and parkinson’s disease-type pathology. Neurobiol. Aging 35, 2180.e1–2180.e5. doi: 10.1016/j.neurobiolaging.2014.03.024
65. Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., et al. (2015). Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340–344. doi: 10.1038/nature14547
66. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., et al. (1997). Mutation in the alpha-synuclein gene identified in families with parkinson’s disease. Science 276, 2045–2047. doi: 10.1126/science.276.5321.2045
67. Prinz, M., Priller, J., Sisodia, S. S., and Ransohoff, R. M. (2011). Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci. 14, 1227–1235. doi: 10.1038/nn.2923
68. Proukakis, C., Dudzik, C. G., Brier, T., MacKay, D. S., Cooper, J. M., Millhauser, G. L., et al. (2013). A novel a-synuclein missense mutation in parkinson disease. Neurology 80, 1062–1064. doi: 10.1212/WNL.0b013e31828727ba
69. Prusiner, S. B., Woerman, A. L., Mordes, D. A., Watts, J. C., Rampersaud, R., Berry, D. B., et al. (2015). Evidence for a-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc. Natl. Acad. Sci. U S A 112, E5308–E5317. doi: 10.1073/pnas.1514475112
70. Radford, R., Rcom-H’Cheo-Gauthier, A., Wong, M. B., Eaton, E. D., Quilty, M., Blizzard, C., et al. (2015). The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to a-synuclein inclusions. Mol. Cell. Neurosci. 65, 68–81. doi: 10.1016/j.mcn.2015.02.015
71. Radford, R., Wong, M., and Pountney, D. L. (2014). Neurodegenerative aspects of multiple system atrophy. Handb. Neurotox. 2157–2180. doi: 10.1007/978-1-4614-5836-4_110
72. Reyes, J. F., Rey, N. L., Bousset, L., Melki, R., Brundin, P., and Angot, E. (2014). Alpha-synuclein transfers from neurons to oligodendrocytes. Glia 62, 387–398. doi: 10.1002/glia.22611
73. Roberts, H. L., and Brown, D. R. (2015). Seeking a mechanism for the toxicity of oligomeric a-synuclein. Biomolecules 5, 282–305. doi: 10.3390/biom5020282
74. Sanchez-Guajardo, V., Tentillier, N., and Romero-Ramos, M. (2015). The relation between a-synuclein and microglia in parkinson’s disease: recent developments. Neuroscience 302, 47–58. doi: 10.1016/j.neuroscience.2015.02.008
75. Scheffel, J., Regen, T., Van Rossum, D., Seifert, S., Ribes, S., Nau, R., et al. (2012). Toll-like receptor activation reveals developmental reorganization and unmasks responder subsets of microglia. Glia 60, 1930–1943. doi: 10.1002/glia.22409
76. Schocke, M., Seppi, K., Esterhammer, R., Kremser, C., Jaschke, W., Poewe, W., et al. (2002). Diffusion-weighted MRI differentiates the parkinson variant of multiple system atrophy from PD. Neurology 58, 575–580. doi: 10.1212/wnl.58.4.575
77. Schrag, A., Kingsley, D., Phatouros, C., Mathias, C., Lees, A., Daniel, S., et al. (1998). Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J. Neurol. Neurosurg. Psychiatry 65, 65–71. doi: 10.1136/jnnp.65.1.65
78. Shastri, A., Bonifati, D. M., and Kishore, U. (2013). Innate immunity and neuroinflammation. Mediators Inflamm. 2013:342931. doi: 10.1155/2013/342931
79. Shulman, J. M., De Jager, P. L., and Feany, M. B. (2011). Parkinson’s disease: genetics and pathogenesis. Annu. Rev. Pathol. 6, 193–222. doi: 10.1146/annurev-pathol-011110-130242
80. Singh, S., Mishra, A., and Shukla, S. (2015). Alcar exerts neuroprotective and pro-neurogenic effects by inhibition of glial activation and oxidative stress via activation of the wnt/ß-catenin signaling in parkinsonian rats. Mol. Neurobiol. doi: 10.1007/s12035-015-9361-5 [Epub ahead of print].
81. Skaper, S., Facci, L., Barbierato, M., Zusso, M., Bruschetta, G., Impellizzeri, D., et al. (2015). N-Palmitoylethanolamine and neuroinflammation: a novel therapeutic strategy of resolution. Mol. Neurobiol. 52, 1034–1042. doi: 10.1007/s12035-015-9253-8
82. Sofroniew, M. V., and Vinters, H. V. (2010). Astrocytes: biology and pathology. Acta Neuropathol. 119, 7–35. doi: 10.1007/s00401-009-0619-8
83. Song, Y. J. C. P., Halliday, G. M. P., Holton, J. L. P. F., Lashley, T. P., O’Sullivan, S. S. M., McCann, H. B., et al. (2009). Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. J. Neuropathol. Exp. Neurol. 68, 1073–1083. doi: 10.1097/nen.0b013e3181b66f1b
84. Spencer, B., Valera, E., Rockenstein, E., Trejo-Morales, M., Adame, A., and Masliah, E. (2015). A brain-targeted, modified neurosin (kallikrein-6) reduces a-synuclein accumulation in a mouse model of multiple system atrophy. Mol. Neurodegen. 10:48. doi: 10.1186/s13024-015-0043-6
85. Stefanova, N., Reindl, M., Neumann, M., Haass, C., Poewe, W., Kahle, P. J., et al. (2005). Oxidative stress in transgenic mice with oligodendroglial a-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am. J. Pathol. 166, 869–876. doi: 10.1016/s0002-9440(10)62307-3
86. Stefanova, N., Reindl, M., Neumann, M., Kahle, P. J., Poewe, W., and Wenning, G. K. (2007). Microglial activation mediates neurodegeneration related to oligodendroglial a-synucleinopathy: implications for multiple system atrophy. Mov. Disord. 22, 2196–2203. doi: 10.1002/mds.21671
87. Stemberger, S., Jamnig, A., Stefanova, N., Lepperdinger, G., Reindl, M., and Wenning, G. K. (2011). Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection. PLoS One 6:e19808. doi: 10.1371/journal.pone.0019808
88. Takeuchi, H. (2013). Roles of glial cells in neuroinflammation and neurodegeneration. Clin. Exp. Neuroimmunol. 4, 2–16. doi: 10.1111/cen3.12059
89. Tang, Y., and Le, W. (2015). Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol. Neurobiol. doi: 10.1007/s12035-014-9070-5 [Epub ahead of print].
90. Tanik, S. A., Schultheiss, C. E., Volpicelli-Daley, L. A., Brunden, K. R., and Lee, V. M. (2013). Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy. J. Biol. Chem. 288, 15194–15210. doi: 10.1074/jbc.M113.457408
91. Tenreiro, S., ReimÃo-Pinto, M. M., Antas, P., Rino, J., Wawrzycka, D., Macedo, D., et al. (2014). Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of parkinson’s disease. PLoS Genet. 10:e1004302. doi: 10.1371/journal.pgen.1004302
92. Thakur, P., and Nehru, B. (2015). Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of parkinson’s disease. Mol. Neurobiol. 51, 209–219. doi: 10.1007/s12035-014-8769-7
93. Tien, L.-T., Kaizaki, A., Pang, Y., Cai, Z., Bhatt, A. J., and Fan, L.-W. (2013). Neonatal exposure to lipopolysaccharide enhances accumulation of a-synuclein aggregation and dopamine transporter protein expression in the substantia nigra in responses to rotenone challenge in later life. Toxicology 308, 96–103. doi: 10.1016/j.tox.2013.03.014
94. Togo, T., and Dickson, D. (2002). Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Acta Neuropathol. 104, 398–402.
95. Tong, J., Wong, H., Guttman, M., Ang, L. C., Forno, L. S., Shimadzu, M., et al. (2009). Brain a-synuclein accumulation in multiple system atrophy, parkinson’s disease and progressive supranuclear palsy: a comparative investigation. Brain 133, 172–188. doi: 10.1093/brain/awp282
96. Trojanowski, J., and Revesz, T. (2007). Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol. App. Neurobiol. 33, 615–620. doi: 10.1111/j.1365-2990.2007.00907.x
97. Ubhi, K., Low, P., and Masliah, E. (2011). Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci. 34, 581–590. doi: 10.1016/j.tins.2011.08.003
98. Valera, E., and Masliah, E. (2013). Immunotherapy for neurodegenerative diseases: focus on a-synucleinopathies. Pharmacol. Ther. 138, 311–322. doi: 10.1016/j.pharmthera.2013.01.013
99. Vijayakumaran, S., Wong, M., Antony, H., and Pountney, D. (2015). Direct and/or indirect roles for SUMO in modulating alpha-synuclein toxicity. Biomolecules 5, 1697–1716. doi: 10.3390/biom5031697
100. Vilariño-Güell, C., Soto-Ortolaza, A., Rajput, A., Mash, D., Papapetropoulos, S., Pahwa, R., et al. (2011). MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy. Neurology 76, 670–672. doi: 10.1212/wnl.0b013e31820c30c1
101. Watanabe, H., Fukatsu, H., Katsuno, M., Sugiura, M., Hamada, K., Okada, Y., et al. (2004). Multiple regional (1)H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J. Neurol. Neurosurg. Psychiatry 75, 103–109.
102. Watanabe, H., Saito, Y., Terao, S., Ando, T., Kachi, T., Mukai, E., et al. (2002). Progression and prognosis in multiple system atrophy. Brain 125, 1070–1083. doi: 10.1093/brain/awf117
103. Welser-Alves, J. V., and Milner, R. (2013). Microglia are the major source of TNF-a and TGF-ß1 in postnatal glial cultures; regulation by cytokines, lipopolysaccharide and vitronectin. Neurochem. Int. 63, 47–53. doi: 10.1016/j.neuint.2013.04.007
104. Wenning, G. K., Geser, F., Krismer, F., Seppi, K., Duerr, S., Boesch, S., et al. (2013). The natural history of multiple system atrophy: a prospective european cohort study. Lancet Neurol. 12, 264–274. doi: 10.1016/S1474-4422(12)70327-7
105. Wenning, G. K., Stefanova, N., Jellinger, K. A., Poewe, W., and Schlossmacher, M. G. (2008). Multiple system atrophy: a primary oligodendrogliopathy. Ann. Neurol. 64, 239–246. doi: 10.1002/ana.21465
106. Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., et al. (2011). In vivo demonstration that a-synuclein oligomers are toxic. Proc. Natl. Acad. Sci. U S A 108, 4194–4199. doi: 10.1073/pnas.1100976108
107. Woerman, A. L., Stöhr, J., Aoyagi, A., Rampersaud, R., Krejciova, Z., Watts, J. C., et al. (2015). Propagation of prions causing synucleinopathies in cultured cells. Proc. Natl. Acad. Sci. U S A 112, E4949–E4958. doi: 10.1073/pnas.1513426112
108. Wong, M., Goodwin, J., Norazit, A., Meedeniya, A. B., Richter-Landsberg, C., Gai, W., et al. (2013). SUMO-1 is associated with a subset of lysosomes in glial protein aggregate diseases. Neurotox. Res. 23, 1–21. doi: 10.1007/s12640-012-9358-z
109. Xilouri, M., Brekk, O. R., Landeck, N., Pitychoutis, P. M., Papasilekas, T., Papadopoulou-Daifoti, Z., et al. (2013). Boosting chaperone-mediated autophagy in vivo mitigates a-synuclein-induced neurodegeneration. Brain 136, 2130–2146. doi: 10.1093/brain/awt131
110. Xilouri, M., Vogiatzi, T., Vekrellis, K., Park, D., and Stefanis, L. (2009). Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 4:e5515. doi: 10.1371/journal.pone.0005515
111. Zarranz, J. J., Alegre, J., Gómez-esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., et al. (2004). The new mutation, E46K, of a-synuclein causes parkinson and lewy body dementia. Ann. Neurol. 55, 164–173. doi: 10.1002/ana.10795
112. Zhang, W., Yan, Z. F., Gao, J. H., Sun, L., Huang, X. Y., Liu, Z., et al. (2014). Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration. Mol. Neurobiol. 49, 1153–1165. doi: 10.1007/s12035-013-8586-4
113. Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., et al. (2005). Aggregated a-synuclein activates microglia: a process leading to disease progression in parkinson’s disease. FASEB J. 19, 533–542. doi: 10.1096/fj.04-2751com